Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 17.19%13.77M | 3.06%53.04M | 39.97%16.79M | 2.97%13.21M | -7.73%11.29M | -18.43%11.75M | 2.64%51.47M | 4.49%12M | -20.34%12.83M | 25.16%12.23M |
| Cost of revenue | 7.52%9.45M | 6.68%37.15M | 46.12%11.48M | 3.29%9.12M | -11.04%7.77M | -6.61%8.79M | -12.85%34.82M | -11.30%7.85M | -37.06%8.83M | 10.24%8.73M |
| Gross profit | 45.83%4.32M | -4.51%15.89M | 28.32%5.32M | 2.27%4.1M | 0.51%3.52M | -40.68%2.97M | 63.39%16.64M | 57.76%4.14M | 92.27%4.01M | 89.03%3.5M |
| Operating expense | -14.86%2.35M | 7.95%12.6M | -87.17%322K | 1.52%2.07M | 14.76%2.68M | 23.22%2.76M | 11.00%11.67M | -40.18%2.51M | -9.39%2.04M | -0.64%2.34M |
| Selling and administrative expenses | 4.80%2.56M | 8.38%10.64M | 25.99%2.38M | -9.23%2.27M | 37.73%3.55M | -13.85%2.44M | 14.08%9.82M | -8.45%1.89M | 5.12%2.5M | 35.95%2.58M |
| -Selling and marketing expense | 2.26%226K | -2.78%831.93K | 38.86%268K | -24.55%166K | -3.80%177K | -14.67%221K | 63.33%855.73K | 42.00%193K | 122.22%220K | 60.00%184K |
| -General and administrative expense | 5.05%2.33M | 9.44%9.81M | 24.53%2.11M | -7.75%2.11M | 40.92%3.38M | -13.76%2.22M | 10.88%8.97M | -12.01%1.7M | 0.04%2.28M | 34.40%2.4M |
| Other operating expenses | -68.99%312K | 1.33%2.13M | -4.22%771K | -94.87%18K | 0.61%332K | 63.84%1.01M | -4.86%2.1M | -36.05%805K | 92.86%351K | -27.63%330K |
| Total other operating income | -24.34%519K | -30.74%173.97K | 1,429.19%2.83M | -72.56%225K | 110.33%1.2M | -43.12%686K | -17.12%251.2K | 121.22%185K | 157.86%820K | --571K |
| Operating profit | 858.74%1.98M | -33.75%3.3M | 205.76%4.99M | 3.05%2.03M | -28.17%834K | -92.53%206K | 1,622.61%4.97M | 204.10%1.63M | 1,308.59%1.97M | 331.27%1.16M |
| Net non-operating interest income (expenses) | 15.15%-28K | 37.91%1.67M | 250.00%3K | 5.88%-32K | 13.51%-32K | 10.81%-33K | 44.03%1.21M | -100.21%-2K | -3.03%-34K | -5.71%-37K |
| Non-operating interest income | ---- | 33.60%1.77M | --3K | ---- | ---- | ---- | 38.67%1.32M | ---- | ---- | ---- |
| Non-operating interest expense | -15.15%28K | -14.11%94.19K | ---- | -5.88%32K | -13.51%32K | -10.81%33K | -1.78%109.66K | -85.35%2K | 3.03%34K | 5.71%37K |
| Net investment income | -28.19%565.66K | -58.79%787.73K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 1,457.45%2.13M | -30.71%136.77K | ||||||||
| Less:Other special charges | ---- | -1,457.45%-2.13M | ---- | ---- | ---- | ---- | 30.71%-136.77K | ---- | ---- | ---- |
| Other non-operating income (expenses) | 1.00%303.73K | 108.70%300.73K | ||||||||
| Income before tax | 1,025.43%1.95M | 7.49%7.97M | 206.32%5M | 3.20%2M | -28.65%802K | -93.64%173K | 167.71%7.41M | 0.37%1.63M | 1,087.76%1.94M | 309.31%1.12M |
| Income tax | 596.92%453K | -29.29%1.62M | 60.59%599K | -30.52%437K | -19.32%522K | -89.94%65K | 135.94%2.3M | -45.20%373K | 2,346.43%629K | 1,024.29%647K |
| Net income | 1,283.33%1.49M | 23.99%6.35M | 249.52%4.4M | 19.43%1.56M | -41.30%280K | -94.80%108K | 184.92%5.12M | 26.52%1.26M | 916.88%1.31M | 180.98%477K |
| Net income continuous operations | 1,283.33%1.49M | 23.99%6.35M | 249.52%4.4M | 19.43%1.56M | -41.30%280K | -94.80%108K | 184.92%5.12M | 33.22%1.26M | 877.98%1.31M | 202.14%477K |
| Net income discontinuous operations | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 525.00%50K | ---- |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 1,283.33%1.49M | 23.99%6.35M | 249.52%4.4M | 19.43%1.56M | -41.30%280K | -94.80%108K | 184.92%5.12M | 26.52%1.26M | 916.88%1.31M | 180.98%477K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 1,283.33%1.49M | 23.99%6.35M | 249.52%4.4M | 19.43%1.56M | -41.30%280K | -94.80%108K | 184.92%5.12M | 26.52%1.26M | 916.88%1.31M | 180.98%477K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 1,235.71%0.0187 | 23.91%0.0793 | 250.32%0.055 | 19.63%0.0195 | -41.67%0.0035 | -94.62%0.0014 | 184.44%0.064 | 25.60%0.0157 | 915.00%0.0163 | 182.19%0.006 |
| Diluted earnings per share | 1,235.71%0.0187 | 23.91%0.0793 | 250.32%0.055 | 19.63%0.0195 | -41.67%0.0035 | -94.62%0.0014 | 184.44%0.064 | 26.32%0.0157 | 915.00%0.0163 | 182.19%0.006 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0.00%0.035 | 0 | 0 | 0.00%0.035 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.